Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lagercrantz Group in connection with acquisition of Plåt & Spiralteknik
Mandate

Vinge advises Lagercrantz Group in connection with acquisition of Plåt & Spiralteknik

July 03, 2012

Vinge has advised Lagercrantz Group in connection with the acquisition of the entire issued share capital in Plåt & Spiralteknik i Torsås AB, a company which develops, manufactures and markets shaftless spiral conveyors to customers within the biofuel, treatment plant, sawmills and recycling industries.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Nicolina Kindblom, Johan Cederblad and Daniel Järmén.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026